Quoin Pharmaceuticals Ltd Stock Alpha and Beta Analysis
| QNRX Stock | USD 0.30 0.01 3.45% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Quoin Pharmaceuticals Ltd. It also helps investors analyze the systematic and unsystematic risks associated with investing in Quoin Pharmaceuticals over a specified time horizon. Remember, high Quoin Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Quoin Pharmaceuticals' market risk premium analysis include:
Beta (0.46) | Alpha (1.11) | Risk 7.75 | Sharpe Ratio (0.08) | Expected Return (0.61) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Quoin |
Quoin Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Quoin Pharmaceuticals market risk premium is the additional return an investor will receive from holding Quoin Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Quoin Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Quoin Pharmaceuticals' performance over market.| α | -1.11 | β | -0.46 |
Quoin Pharmaceuticals expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Quoin Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Quoin Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Quoin Pharmaceuticals Market Price Analysis
Market price analysis indicators help investors to evaluate how Quoin Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Quoin Pharmaceuticals shares will generate the highest return on investment. By understating and applying Quoin Pharmaceuticals stock market price indicators, traders can identify Quoin Pharmaceuticals position entry and exit signals to maximize returns.
Quoin Pharmaceuticals Return and Market Media
The median price of Quoin Pharmaceuticals for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 is 0.33 with a coefficient of variation of 35.07. The daily time series for the period is distributed with a sample standard deviation of 0.15, arithmetic mean of 0.43, and mean deviation of 0.14. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Fujian Wanchen Biotechnology Group Could Become A Multi-Bagger | 02/24/2025 |
2 | Q4 2024 Puma Biotechnology Inc Earnings Call Transcript | 02/28/2025 |
3 | Cryostat Market to Hit USD 3.69 Billion by 2032 Driven by Advancements in Healthcare and Biotechnology SNS Insider | 03/05/2025 |
4 | Quoin Pharmaceuticals, Ltd. Short Interest Up 5,936.0 percent in February | 03/12/2025 |
5 | iNtRON Biotechnology Full Year 2024 Earnings 79.00 loss per share | 03/13/2025 |
6 | Anhui Anke Biotechnology Co., Ltd.s largest shareholders are retail investors with 52 percent ownership, insiders own 38 | 03/14/2025 |
7 | QNRX With Clinical Activities Expanding, QNRX Expects Cash Runway Into 2Q26 | 03/17/2025 |
8 | MAIA Biotechnology Receives USAN Council Approval for Ateganosine as Nonproprietary Name for Anticancer Agent THIO | 03/19/2025 |
About Quoin Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Quoin or other stocks. Alpha measures the amount that position in Quoin Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Quoin Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of Quoin Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Quoin Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Quoin Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Quoin Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Quoin Pharmaceuticals' management manipulating its earnings.
| 13th of March 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 13th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Quoin Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Quoin Stock Analysis
When running Quoin Pharmaceuticals' price analysis, check to measure Quoin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quoin Pharmaceuticals is operating at the current time. Most of Quoin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Quoin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quoin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Quoin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.